...
cris-img

Curis Inc, Common Stock

CRIS

NAQ

$3.07

-$0.15

(-4.66%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$27.26M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
149.20K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
3.35
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.05 L
$17.49 H
$3.07

About Curis Inc, Common Stock

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; CA-170, an oral, small molecule antagonist designated as CA-170 that selectively targets PD-L1 and VISTA; and CA-327, an oral, small molecule, TIM3/PD-L1, which is a molecule antagonist of PD-L1 and TIM3. It has collaboration agreement with Genentech Inc., or Genentech and F. Hoffmann-La Roche Ltd, or Roche, for the commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway antagonist for the treatment of advanced basal cell carcinoma, or BCC; Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and also licensed four programs under the Aurigene collaboration, including emavusertib. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCRISSectorS&P500
1-Week Return-17.47%-3.35%-2.97%
1-Month Return-19%-3.49%-0.66%
3-Month Return-48.23%-12.6%2.71%
6-Month Return-61.43%-6.91%7.21%
1-Year Return-74.54%1.19%23.04%
3-Year Return-96.85%-0.21%28.43%
5-Year Return-89.97%33.09%82.88%
10-Year Return-97.38%93.55%184.63%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue10.00M10.84M10.65M10.16M10.02M[{"date":"2019-12-31","value":92.33,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.28,"profit":true},{"date":"2022-12-31","value":93.79,"profit":true},{"date":"2023-12-31","value":92.51,"profit":true}]
Cost of Revenue503.00K534.00K533.00K257.00K229.00K[{"date":"2019-12-31","value":94.19,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.81,"profit":true},{"date":"2022-12-31","value":48.13,"profit":true},{"date":"2023-12-31","value":42.88,"profit":true}]
Gross Profit9.50M10.30M10.12M9.90M10.02M[{"date":"2019-12-31","value":92.23,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.2,"profit":true},{"date":"2022-12-31","value":96.16,"profit":true},{"date":"2023-12-31","value":97.3,"profit":true}]
Gross Margin94.97%95.07%94.99%97.47%100.00%[{"date":"2019-12-31","value":94.97,"profit":true},{"date":"2020-12-31","value":95.07,"profit":true},{"date":"2021-12-31","value":94.99,"profit":true},{"date":"2022-12-31","value":97.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses33.86M35.20M52.18M62.92M58.35M[{"date":"2019-12-31","value":53.81,"profit":true},{"date":"2020-12-31","value":55.94,"profit":true},{"date":"2021-12-31","value":82.93,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.74,"profit":true}]
Operating Income(24.36M)(24.90M)(42.06M)(53.02M)(48.33M)[{"date":"2019-12-31","value":-2435600000,"profit":false},{"date":"2020-12-31","value":-2489800000,"profit":false},{"date":"2021-12-31","value":-4206500000,"profit":false},{"date":"2022-12-31","value":-5302000000,"profit":false},{"date":"2023-12-31","value":-4833200000,"profit":false}]
Total Non-Operating Income/Expense(12.02M)(10.04M)(7.63M)(7.30M)(1.04M)[{"date":"2019-12-31","value":-1201700000,"profit":false},{"date":"2020-12-31","value":-1004200000,"profit":false},{"date":"2021-12-31","value":-763200000,"profit":false},{"date":"2022-12-31","value":-730400000,"profit":false},{"date":"2023-12-31","value":-103700000,"profit":false}]
Pre-Tax Income(32.14M)(29.91M)(45.44M)(56.67M)(47.41M)[{"date":"2019-12-31","value":-3214100000,"profit":false},{"date":"2020-12-31","value":-2990800000,"profit":false},{"date":"2021-12-31","value":-4543600000,"profit":false},{"date":"2022-12-31","value":-5667200000,"profit":false},{"date":"2023-12-31","value":-4741300000,"profit":false}]
Income Taxes4.66M4.97M5.20M3.65M(255.00K)[{"date":"2019-12-31","value":89.6,"profit":true},{"date":"2020-12-31","value":95.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.18,"profit":true},{"date":"2023-12-31","value":-4.9,"profit":false}]
Income After Taxes(36.80M)(34.88M)(50.64M)(60.32M)(47.16M)[{"date":"2019-12-31","value":-3680400000,"profit":false},{"date":"2020-12-31","value":-3488100000,"profit":false},{"date":"2021-12-31","value":-5064000000,"profit":false},{"date":"2022-12-31","value":-6032400000,"profit":false},{"date":"2023-12-31","value":-4715800000,"profit":false}]
Income From Continuous Operations(32.14M)(29.91M)(45.44M)(56.67M)(47.03M)[{"date":"2019-12-31","value":-3214100000,"profit":false},{"date":"2020-12-31","value":-2990800000,"profit":false},{"date":"2021-12-31","value":-4543600000,"profit":false},{"date":"2022-12-31","value":-5667200000,"profit":false},{"date":"2023-12-31","value":-4703000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(36.80M)(34.88M)(50.64M)(60.32M)(47.41M)[{"date":"2019-12-31","value":-3680400000,"profit":false},{"date":"2020-12-31","value":-3488100000,"profit":false},{"date":"2021-12-31","value":-5064000000,"profit":false},{"date":"2022-12-31","value":-6032400000,"profit":false},{"date":"2023-12-31","value":-4741300000,"profit":false}]
EPS (Diluted)(19.40)(0.67)(0.50)(0.61)(4.40)[{"date":"2019-12-31","value":-1940,"profit":false},{"date":"2020-12-31","value":-67,"profit":false},{"date":"2021-12-31","value":-50,"profit":false},{"date":"2022-12-31","value":-61,"profit":false},{"date":"2023-12-31","value":-440,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CRIS
Cash Ratio 0.95
Current Ratio 1.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CRIS
ROA (LTM) -45.97%
ROE (LTM) -372.68%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CRIS
Debt Ratio Lower is generally better. Negative is bad. 1.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.21

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CRIS
Trailing PE NM
Forward PE NM
P/S (TTM) 2.68
P/B 4.32
Price/FCF NM
EV/R 1.13
EV/Ebitda 0.56
PEG NM

FAQs

What is Curis Inc share price today?

Curis Inc (CRIS) share price today is $3.07

Can Indians buy Curis Inc shares?

Yes, Indians can buy shares of Curis Inc (CRIS) on Vested. To buy Curis Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CRIS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Curis Inc be purchased?

Yes, you can purchase fractional shares of Curis Inc (CRIS) via the Vested app. You can start investing in Curis Inc (CRIS) with a minimum investment of $1.

How to invest in Curis Inc shares from India?

You can invest in shares of Curis Inc (CRIS) via Vested in three simple steps:

  • Click on Sign Up or Invest in CRIS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Curis Inc shares
What is Curis Inc 52-week high and low stock price?

The 52-week high price of Curis Inc (CRIS) is $17.49. The 52-week low price of Curis Inc (CRIS) is $3.05.

What is Curis Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Curis Inc (CRIS) is

What is Curis Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Curis Inc (CRIS) is 4.32

What is Curis Inc dividend yield?

The dividend yield of Curis Inc (CRIS) is 0.00%

What is the Market Cap of Curis Inc?

The market capitalization of Curis Inc (CRIS) is $27.26M

What is Curis Inc’s stock symbol?

The stock symbol (or ticker) of Curis Inc is CRIS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top